INSL5 (RXFP3 Receptor) h(CD28-CD3ζ) Ligand-based CAR, pCDCAR1 from Creative Biolabs

The vector of INSL5 chimeric antigen receptor (CAR) is a ligand-based CAR constructed for the engineering of T cells to target human RXFP3. The T cells are genetically modified through transduction with a lentiviral vector expressing expressing protein of PD-1 INSL5 linked to CD28 and CD3ζ signaling domains